July 29, 2022 – Release at 7:30am BST
Sophia Antipolis, France
Nicox S.A FR COX))), an international eye care company, announced today that Jean-Francois Labbé, a Board Member of Nicox SA, has been appointed Chairman of the Board of Nicox, effective July 28, 2022 meanwhile remains on the board since June 1, 2022.
“I record this role at a very exciting time for the company having recently joined us as Chief Executive Officer Andreas Segerros and with our first pivotal Phase 3 dates on NCX470 in glaucoma due in November of this year. I look forward to working with Andreas and the leadership team as we prepare Nicox to continue its development based on the clinical data of the NCX 470.” said Jean Francois Labbe, chairman by Nicox. “On behalf of the company and the Board of Directors, I would like to express my appreciation for the leadership, commitment and motivation of MIchele Garufi, both as chairman and as Ccalled EManaging Director Oofficersince the company was founded. We look forward to continuing to benefit from his experience through his position on the Nicox Board of Directors.“
“The appointment of Jean-Francois Labbe as CEO completes the board and management reorganization that began when I joined the company two months ago. The company is well positioned for the future a strong and experienced management and a supportive and effective blackboardin a good governance structure.” said Andreas Segerros, Chief Executive Officer of Nicox.
Jean Francois Labbe
Jean-François Labbé has been a member of Nicox’s Board of Directors since June 2010 and Chairman of Nicox’s Audit Committee since July 2013. M. Labbé is the founder and Chief Executive Officer of SpePharm Holding BV, a pan-European specialty pharmaceutical company. Before founding SpePharm, M. Labbé was Chief Executive Officer of OTL Pharma SA from 2001 to 2004 and as…